Clinical Trial

Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants

Name: Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants — clinical trial record (NCT07419698)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A This is a single-center, randomized, double-blind, placebo-controlled, dose-escalation Phase I clinical trial. It aims to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single administration of JMT206 Injection in healthy participants.

Trial Details

NCT Number	NCT07419698
Lead Sponsor	Shanghai JMT-Bio Inc.
Conditions	Healthy Participants
Enrollment	44 participants
Start Date	2026-01-26
Primary Completion	2026-09-01 (estimated)
Study Completion	2026-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-19